Cargando…

Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial

Renal denervation (RDN) lowers blood pressure (BP), but BP response is variable in individual patients. We investigated whether measures of pulsatile hemodynamics, obtained during 24-hour ambulatory BP monitoring, predict BP drop following RDN. METHODS: From the randomized, sham-controlled SPYRAL HT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Thomas, Wassertheurer, Siegfried, Mayer, Christopher C., Hametner, Bernhard, Danninger, Kathrin, Townsend, Raymond R., Mahfoud, Felix, Kario, Kazuomi, Fahy, Martin, DeBruin, Vanessa, Peterson, Nicole, Negoita, Manuela, Weber, Michael A., Kandzari, David E., Schmieder, Roland E., Tsioufis, Konstantinos P., Binder, Ronald K., Böhm, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172874/ https://www.ncbi.nlm.nih.gov/pubmed/35582957 http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.18641

Ejemplares similares

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
por: Weber, Michael A., et al.
Publicado: (2022)

A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
por: Böhm, Michael, et al.
Publicado: (2021)

Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2017)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
por: Kirtane, Ajay J., et al.
Publicado: (2023)

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study
por: Saxena, Manish, et al.
Publicado: (2021)

Renal denervation after the symplicity HTN-3 trial
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2014)

Renal Denervation after Symplicity HTN-3: An Update
por: Persu, Alexandre, et al.
Publicado: (2014)

SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
por: Patel, Hitesh C, et al.
Publicado: (2014)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial
por: Azizi, Michel, et al.
Publicado: (2022)

Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model
por: Wolf, Milan, et al.
Publicado: (2018)

Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study
por: Kario, Kazuomi, et al.
Publicado: (2020)

Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension
por: Fadl Elmula, Fadl Elmula M., et al.
Publicado: (2015)

Heart Failure: Insights From the Arterial Waves
por: Hametner, Bernhard, et al.
Publicado: (2023)

Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria
por: Schönherr, Elisabeth, et al.
Publicado: (2016)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

Assessment of central haemomodynamics from a brachial cuff in a community setting
por: Nunan, David, et al.
Publicado: (2012)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Khanal, Suraj, et al.
Publicado: (2014)

Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Wave intensity of aortic root pressure as diagnostic marker of left ventricular systolic dysfunction
por: Hametner, Bernhard, et al.
Publicado: (2017)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment
por: Kario, Kazuomi, et al.
Publicado: (2021)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
por: Sharp, Andrew S.P., et al.
Publicado: (2022)

Relationship Between Portal HTN and Cirrhosis as a Cause for Diabetes
por: Djiambou-Nganjeu, Herbert
Publicado: (2019)

Pulsatile Hemodynamics and Coronary Artery Disease
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)

Unveiling the Vascular Mechanisms Behind Long‐Term Effects of Coarctation Treatment Using Pulse Wave Dynamics
por: Hametner, Bernhard, et al.
Publicado: (2019)

Renal Denervation in Daily Practice: If So, How?
por: Millenaar, Dominic, et al.
Publicado: (2020)

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

A Japan nationwide web‐based survey of estimation on patients for renal denervation based on blood pressure level and the number of antihypertensives (J‐NEEDs survey)
por: Kagitani, Hideaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m5965ijce08pemsbegkeqrt79c